Skip to main content

Table 2 Clinical Grobal Impressions-Severity at baseline and the end of treatment

From: Dosage, effectiveness, and safety of sertraline treatment for posttraumatic stress disorder in a Japanese clinical setting: a retrospective study

Baseline N = 122 The end of sertraline treatment or the last observation N = 122
Normal Borderline Mild Moderate Marked Severe Most severe Not assessed
13 (10.7) 19 (15.6) 40 (32.8) 40 (32.8) 4 (3.3) 5 (4.1) 1 (0.8) 0
Normal 0 0 0 0 0 0 0 0 0
Borderline 0 0 0 0 0 0 0 0 0
Mild 16 (13.1) 3 (2.5) 4 (3.3) 7 (5.7) 2 (1.6) 0 0 0 0
Moderate 68 (55.7) 6 (4.9) 11 (9.0) 26 (21.3) 25 (20.5) 0 0 0 0
Marked 17 (13.9) 2 (1.6) 1 (0.8) 4 (3.3) 8 (6.6) 2 (1.6) 0 0 0
Severe 20 (16.4) 2 (1.6) 3 (2.5) 3 (2.5) 5 (4.1) 2 (1.6) 5 (4.1) 0 0
Most severe 1 (0.8) 0 0 0 0 0 0 1 (0.8) 0
Not assessed 0 0 0 0 0 0 0 0 0
  1. Values represent the number (%) of patients
  2. Bold = patients who showed improvement in severity from baseline
  3. Normal, normal, not at all ill, Borderline borderline mentally ill, Mild mildly ill, Moderate moderately ill, Marked markedly ill, Severe severely ill, Most severe most severely ill